Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junna Oba

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Journal of Dermatology|May 19, 2021
The genetic and epigenetic basis of distinct melanoma typesJunna Oba, Scott E Woodman
Risk Management and Healthcare Policy|March 26, 2024
Using a Systems Engineering Approach to Build a PCR Testing System at a Medical School During the COVID-19 PandemicJunna Oba, Masako Toriya, Yoshifumi Uwamino, et al.
The Journal of Dermatology|November 24, 2017
Non-corticosteroid adherence and itch severity influence perception of itch in atopic dermatitisSatoshi Takeuchi, Junna Oba, Hitokazu Esaki, et al.
The Journal of Investigative Dermatology|January 15, 2016
Early Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma ProgressionTakeshi Nakahara, Junna Oba, Chie Shimomura, et al.
Journal of Dermatological Science|April 2, 2011
Expression of c-Kit, p-ERK and cyclin D1 in malignant melanoma: an immunohistochemical study and analysis of prognostic valueJunna Oba, Takeshi Nakahara, Takeru Abe, et al.
Plos One|May 13, 2022
SARS-CoV-2 RT-qPCR testing of pooled saliva samples: A case study of 824 asymptomatic individuals and a questionnaire survey in JapanJunna Oba, Hiroaki Taniguchi, Masae Sato, et al.
JMA Journal|February 10, 2025
Medical AI and AI for Medical SciencesKazuhiro Sakurada, Tetsuo Ishikawa, Junna Oba, et al.
Archives of Dermatological Research|November 16, 2010
CD10-bearing fibroblasts may inhibit skin inflammation by down-modulating substance PLining Xie, Masakazu Takahara, Takeshi Nakahara, et al.
Plos One|February 17, 2016
CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor PrognosisJunna Oba, Takeshi Nakahara, Akiko Hashimoto-Hachiya, et al.
Melanoma Research|November 24, 2011
The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in JapanTakamichi Ito, Yoichi Moroi, Junna Oba, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Dermatology|May 19, 2021
The genetic and epigenetic basis of distinct melanoma typesJunna Oba, Scott E Woodman
Risk Management and Healthcare Policy|March 26, 2024
Using a Systems Engineering Approach to Build a PCR Testing System at a Medical School During the COVID-19 PandemicJunna Oba, Masako Toriya, Yoshifumi Uwamino, et al.
The Journal of Dermatology|November 24, 2017
Non-corticosteroid adherence and itch severity influence perception of itch in atopic dermatitisSatoshi Takeuchi, Junna Oba, Hitokazu Esaki, et al.
The Journal of Investigative Dermatology|January 15, 2016
Early Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma ProgressionTakeshi Nakahara, Junna Oba, Chie Shimomura, et al.
Journal of Dermatological Science|April 2, 2011
Expression of c-Kit, p-ERK and cyclin D1 in malignant melanoma: an immunohistochemical study and analysis of prognostic valueJunna Oba, Takeshi Nakahara, Takeru Abe, et al.
Plos One|May 13, 2022
SARS-CoV-2 RT-qPCR testing of pooled saliva samples: A case study of 824 asymptomatic individuals and a questionnaire survey in JapanJunna Oba, Hiroaki Taniguchi, Masae Sato, et al.
JMA Journal|February 10, 2025
Medical AI and AI for Medical SciencesKazuhiro Sakurada, Tetsuo Ishikawa, Junna Oba, et al.
Archives of Dermatological Research|November 16, 2010
CD10-bearing fibroblasts may inhibit skin inflammation by down-modulating substance PLining Xie, Masakazu Takahara, Takeshi Nakahara, et al.
Plos One|February 17, 2016
CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor PrognosisJunna Oba, Takeshi Nakahara, Akiko Hashimoto-Hachiya, et al.
Melanoma Research|November 24, 2011
The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in JapanTakamichi Ito, Yoichi Moroi, Junna Oba, et al.
Pageof 3